Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Why use automatic rebalancing? It helps maintain risk targets, lowers discipline gaps, and frees you from constant manual monitoring.
22,122 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Powell pledges to stay on the Federal Reserve board until the DOJ probe concludes, as Trump presses to replace him. T...
A Seattle wage rule for gig-delivery drivers raised base pay, but researchers say monthly take-home barely rose as dr...
Nvidia delivered a record-breaking quarter, but a steely market mood leaves its stock rangebound. A steward partners ...
Bitcoin holders are feeling the bite as higher gas bills and elevated mortgage costs reshape household budgets and cr...
Markets rally as rate expectations shift, lifting banks and fintechs. This week’s financial stocks week highlights th...
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
Chevron’s CEO warned that oil prices are still too low given the ongoing Strait of Hormuz disruption. Markets have no...
DoorDash sits near 52-week levels after a tough quarter that piled up costs from Deliveroo and grocery pushes. Yet Wa...
A $3 million retirement nest egg offers substantial income options, but taxes, Medicare costs, and withdrawal strateg...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
Hybrids now make up about 20% of U.S. vehicle sales in Q4 2025, signaling a major shift in consumer buying and the tr...